Concepedia

Publication | Closed Access

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses

DOI

354

Citations

14

References

2006

Year

P. O’Connor, D. Li, M. S. Freedman, Amit Bar‐Or, George P. Rice, Christian Confavreux, D. W. Paty, Jeffrey A. Stewart, Richard D. Scheyer
Neurology

Abstract

Oral teriflunomide was effective in reducing MRI lesions and was well tolerated in patients with relapsing multiple sclerosis.

References

YearCitations

Page 1